CYP2D6 genotype and outcome in tamoxifen treated early breast cancer
Background and purpose: The clinical significance of individual CYP2D6 activity for the outcome of tamoxifen treatment in early breast cancer is unclear. Our previous investigation in patients diagnosed over the period 1998–2000 indicated an association between reduced CYP2D6 activity and poor outco...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Medical Journals Sweden
2025-07-01
|
| Series: | Acta Oncologica |
| Subjects: | |
| Online Access: | https://medicaljournalssweden.se/actaoncologica/article/view/43208 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|